Cancer statistics, 2023

Siegel, Rebecca L., Miller, Kimberly D., Wagle, Nikita Sandeep, Jemal, Ahmedin·2023·CA: A Cancer Journal for Clinicians
DOI 10.3322/caac.21763

Cited by (1,029)

Items 401–500 of 1,029

  1. Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial
    Marina Baretti, Ludmila Danilova, Jennifer N. Durham, Courtney B. Betts, Leslie Cope, Dimitrios N. Sidiropoulos, Joseph A. Tandurella, Soren Charmsaz, Nicole Groß, Alexei Hernandez et al. · 2024 · Nature Communications
  2. The Intriguing Connection Between the Gut and Lung Microbiomes
    Magdalena Druszczyńska, Beata Sadowska, Jakub Kulesza, Nikodem Gąsienica-Gliwa, Ewelina Kulesza, Marek Fol · 2024 · Pathogens
  3. Chiral polypeptide hydrogels regulating local immune microenvironment and anti-tumor immune response
    Junfeng Ding, Tianran Wang, Zhiqiang Lin, Zhenyu Li, Jiaxuan Yang, Fujiang Li, Yan Rong, Xuesi Chen, Chaoliang He · 2025 · Nature Communications
  4. New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations
    Ilaria Attili, Carla Corvaja, Gianluca Spitaleri, Ester Del Signore, Pamela Trillo Aliaga, Antonio Passaro, Filippo de Marinis · 2023 · Cancers
  5. Drug resistance mechanisms in cancers: Execution of pro-survival strategies
    Pavan Kumar Dhanyamraju · 2023 · Journal of Biomedical Research
  6. Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
    Giorgio Bogani, Robert Louis Coleman, Ignace B. Vergote, Toon Van Gorp, Isabelle Laure Ray-Coquard, Ana Oaknin, Ursula A. Matulonis, David M. O’Malley, Francesco Raspagliesi, Giovanni Scambia et al. · 2023 · International Journal of Gynecological Cancer
  7. Oncological Applications of Quantum Machine Learning
    Milad Rahimi, Farkhondeh Asadi · 2023 · Technology in Cancer Research & Treatment
  8. Metabolic alterations in hereditary and sporadic renal cell carcinoma
    Nathan J. Coffey, Marie Celeste Simon · 2024 · Nature Reviews Nephrology
  9. Single-cell transcriptome analysis of epithelial, immune, and stromal signatures and interactions in human ovarian cancer
    Chaochao Chai, Langchao Liang, Nanna S. Mikkelsen, Wei Wang, Wandong Zhao, Chengcheng Sun, Rasmus Otkjær Bak, Hanbo Li, Lin Lin, Fei Wang et al. · 2024 · Communications Biology
  10. TPP-based conjugates: potential targeting ligands
    Sanya Batheja, Shruti Gupta, Kiran Kumar Tejavath, Umesh Dutta Gupta · 2024 · Drug Discovery Today
  11. Targeting BRAF pathway in low-grade serous ovarian cancer
    Chiara Perrone, Roberto Angioli, Daniela Luvero, Andrea Giannini, Violante Di Donato, Ilaria Cuccu, Ludovico Muzii, Francesco Raspagliesi, Giorgio Bogani · 2024 · Journal of Gynecologic Oncology
  12. Multifunctional Biomimetic Liposomes with Improved Tumor‐Targeting for TNBC Treatment by Combination of Chemotherapy, Antiangiogenesis and Immunotherapy
    Jinshuai Lan, Lixia Chen, Zhe Li, Li Liu, Ruifeng Zeng, Yitian He, Yi Shen, Tong Zhang, Yue Ding · 2024 · Advanced Healthcare Materials
  13. Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
    Yuhong Wang, Pei Pei, Kai Yang, Lingchuan Guo, Yuan Li · 2024 · Clinical and Translational Medicine
  14. Targeting ferroptosis: a new therapeutic opportunity for kidney diseases
    Zhiyong Long, Yanfang Luo, Min Yu, Xiaoyan Wang, Liuting Zeng, Kailin Yang · 2024 · Frontiers in Immunology
  15. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications
    Zhengjun Lin, Guoqing Li, Ke Jiang, Zhihong Li, Tang Liu · 2024 · Molecular Cancer
  16. Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update
    Kenneth B. Bader, Frederic R. Padilla, Kevin J. Haworth, Nicholas P. K. Ellens, Diane Dalecki, Douglas L. Miller, Keith A. Wear · 2024 · Journal of Ultrasound in Medicine
  17. Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolism
    Ning Wang, Siming Lu, Ziyi Cao, Huimin Li, Junting Xu, Qian Zhou, Hanrui Yin, Qiqi Qian, Xianjing Zhang, Mijia Tao et al. · 2025 · Cell Metabolism
  18. Supramolecular Biomaterials for Cancer Immunotherapy
    Huan Liang, Qingqing Lu, Jie Yang, Guocan Yu · 2023 · Research
  19. Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity
    Zhixiang Chen, Biao Hu, Rohan Kalyan Rej, Dimin Wu, Ranjan Kumar Acharyya, Mingliang Wang, Tianfeng Xu, Jianfeng Lü, Hoda Metwally, Yu Wang et al. · 2023 · Journal of Medicinal Chemistry
  20. Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
    Paraskevi Vryza, Timo Fischer, Elena Mistakidi, Apostolos Zaravinos · 2023 · Translational Oncology
  21. Nanotechnology and Cancer Bioelectricity: Bridging the Gap Between Biology and Translational Medicine
    Rosalia Moreddu · 2023 · Advanced Science
  22. Prostate cancer-derived small extracellular vesicle proteins: the hope in diagnosis, prognosis, and therapeutics
    Haotian Chen, Bairen Pang, Cheng Zhou, Meng Han, Jie Gong, Yong Li, Junhui Jiang · 2023 · Journal of Nanobiotechnology
  23. Exposure to di-2-ethylhexyl phthalate (DEHP) increases the risk of cancer
    Luchen Yang, Xiaoyang Liu, Zhufeng Peng, Zhenghuan Liu, Pan Song, Jing Zhou, Kai Ma, Yunfei Yu, Qiang G Dong · 2024 · BMC Public Health
  24. Natural products reverse cancer multidrug resistance
    Jia-Yu Zou, Qilei Chen, Xiao-Ci Luo, Davaadagva Damdinjav, Usama Ramadan Abdelmohsen, Hongyan Li, Tungalag Battulga, Hubiao Chen, Yuqing Wang, Jianye Zhang · 2024 · Frontiers in Pharmacology
  25. The changing landscape of small cell lung cancer
    Giordano Fabricio Cittolin‐Santos, Brendan J. Knapp, Bharath Ganesh, Feng Gao, Saiama Naheed Waqar, Thomas E. Stinchcombe, Ramaswamy Govindan, Daniel Morgensztern · 2024 · Cancer
  26. Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
    Yo-Ting Tsai, Jeffrey Schlom, Renee Nicole Donahue · 2024 · Journal of Experimental & Clinical Cancer Research
  27. m6A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop
    Yibo Bian, Shufen Xu, Zhishuang Gao, Jie Ding, Chao Li, Zhiwei Cui, Haoyu Sun, Juan Li, Juan Pu, Keming Wang · 2024 · Cancer Letters
  28. Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer
    Zixu Zhang, David Westover, Zhantong Tang, Yue Liu, Jinghan Sun, Yunxi Sun, Runqing Zhang, Xingyue Wang, Shihui Zhou, Nigaerayi Hesilaiti et al. · 2024 · Journal of Translational Medicine
  29. Integration of artificial intelligence in clinical laboratory medicine: Advancements and challenges
    Heying Xie, Yin Hua Jia, Shanrong Liu · 2024 · Interdisciplinary medicine
  30. Chemotoxicity and Associated Risk Factors in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Claire Jungyoun Han, Xia Ning, Christin Elizabeth Burd, Daniel J. Spakowicz, Fode Tounkara, Matthew F. Kalady, Anne M. Noonan, Susan McCabe, Diane M. Von Ah · 2024 · Cancers
  31. Cuproptosis, the novel type of oxidation-induced cell death in thoracic cancers: can it enhance the success of immunotherapy?
    Ruiwen Zhao, Olga A. Sukocheva, Edmund Tse, Неганова Маргарита Евгеньевна, Yulia R. Aleksandrova, Yufei Zheng, Hao Gu, Deyao Zhao, SubbaRao V. Madhunapantula, Xiaorong Zhu et al. · 2024 · Cell Communication and Signaling
  32. Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside
    Elif Çakan, Olivia D. Lara, Anna Szymanowska, Emine Bayraktar, Arturo Chávez‐Reyes, Gabriel Lopez‐Berestein, Paola Amero, Cristian Rodriguez‐Aguayo · 2024 · Cancers
  33. Green synthesis of copper oxide nanoparticles using walnut shell and their size dependent anticancer effects on breast and colorectal cancer cell lines
    Hanieh Abdollahzadeh, Yaghub Pazhang, Asghar Zamani, Yousef Sharafi · 2024 · Scientific Reports
  34. Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications
    Juan Zhang, Yulin Wu, Yuanyang Tian, Hong‐Xi Xu, Zhi‐Xiu Lin, Yan-fang Xian · 2024 · Molecular Cancer
  35. Prognostic value of inflammatory markers NLR, PLR, LMR, dNLR, ANC in melanoma patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
    Yan Ou, Shufang Liang, Qiangqiang Gao, Yongran Shang, Junfang Liang, Weitao Zhang, Sha Liu · 2024 · Frontiers in Immunology
  36. Cancer and sepsis
    Jeroson C. Williams, Mandy L. Ford, Craig M. Coopersmith · 2023 · Clinical Science
  37. State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine
    Tommaso Schepis, Sara Sofia De Lucia, Antonio Pellegrino, Angelo DEL GAUDIO, Rossella Maresca, Gaetano Coppola, Michele Francesco Chiappetta, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli et al. · 2023 · Cancers
  38. Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer
    Wei Zhang, Yibao Fan, Jinze Zhang, Dan Shi, Jiahui Yuan, Milad Ashrafizadeh, Wei Li, Man Hu, A.M. Abd El‐Aty, Ahmet Hacımüftüoğlu et al. · 2023 · Drug Resistance Updates
  39. Oral Complications from Oropharyngeal Cancer Therapy
    Vidya Sankar, Yuanming Xu · 2023 · Cancers
  40. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy
    Raefa Abou Khouzam, Bassam Janji, Jérôme Thiery, Rania Faouzi Zaarour, Ali N. Chamseddine, Hemma Mayr, Pierre Savagner, Claudine Kiéda, Sophie Gad, Stéphanie Buart et al. · 2023 · Seminars in Cancer Biology
  41. The efficacy of progressive muscle relaxation training on cancer-related fatigue and quality of life in patients with cancer: A systematic review and meta-analysis of randomized controlled studies
    Yajiao Wang, Yang Liu, Guijiao Lin, Bichun Huang, Xia Sheng, Ligang Wang, Liuyin Chen, Xiahua Qiu, Xinlei Wu, Rujia Lin · 2024 · International Journal of Nursing Studies
  42. Rational design of a nonclassical liposomal nanoscale drug delivery system for innovative cancer therapy
    Chunjie Wang, Xiaoqi Sun, Liangzhu Feng, Zhuang Liu · 2024 · BMEMat
  43. Immunosenescence and cancer: molecular hallmarks, tumor microenvironment remodeling, and age-specific immunotherapy challenges
    Qianwen Liu, Jingfeng Li, Xiuqiao Sun, Jiayu Lin, Zhengwei Yu, Yue Xiao, Dan Li, Baofa Sun, Haili Bao, Yihao Liu · 2025 · Journal of Hematology & Oncology
  44. Current Trends in Mucosal Melanomas: An Overview
    Davide Adriano Santeufemia, Giuseppe Palmieri, Gianmaria Miolo, Maria Colombino, Maria Grazia Doro, Laura Frogheri, Panagiotis Paliogiannis, Giampiero Capobianco, Massimo Madonia, Antonio Cossu et al. · 2023 · Cancers
  45. Capacity of ChatGPT to Identify Guideline-Based Treatments for Advanced Solid Tumors
    Brian C. Schulte · 2023 · Cureus
  46. Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception
    Arielle J. Medford, Beverly Moy, Laura M. Spring, Sara Alsterlind Hurvitz, Nicholas C. Turner, Aditya Bardia · 2023 · Clinical Cancer Research
  47. [68Ga]Ga-FAPI-04 PET/CT in the evaluation of epithelial ovarian cancer: comparison with [18F]F-FDG PET/CT
    Jie Chen, Kui Xu, Chongjiao Li, Yueli Tian, Ling Li, Bing Wen, Can He, Hongbing Cai, Yong He · 2023 · European Journal of Nuclear Medicine and Molecular Imaging
  48. Fluorescent nano- and microparticles for sensing cellular microenvironment: past, present and future applications
    Giuliana Grasso, Francesco Colella, Stefania Forciniti, Valentina Onesto, Helena Iuele, Anna Chiara Siciliano, Federica Carnevali, Anil Chandra, Giuseppe Gigli, Loretta L. del Mercato · 2023 · Nanoscale Advances
  49. Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety
    Jaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, Julio Cesar Reina, Punnee Pitisuttithum, Àngels Ulied, Linda‐Gail Bekker, Edson Duarte Moreira, Sven‐Eric Olsson, Stan L. Block et al. · 2023 · PEDIATRICS
  50. Epidemiology of pancreatic cancer: New version, new vision
    Wenhao Luo, Jun Wang, Hao Chen, Liyuan Ye, Jiangdong Qiu, Yueze Liu, Ruobing Wang, Guihu Weng, Tao Liu, Dan Su et al. · 2023 · Chinese Journal of Cancer Research
  51. Using hybrid pre-trained models for breast cancer detection
    Sameh Zarif, Hatem Mohamed Abdul-Kader, Ibrahim Sayed Elaraby, Abdullah Alharbi, Wail S. Elkilani, Paweł Pławiak · 2024 · PLoS ONE
  52. Tumor cells are under siege from all sides: Tumor Cell-Mimic Metal−Organic framework nanoparticles triggering Cuproptosis/Ferroptosis/Apoptosis for Chemo-Chemodynamic-Photothermal-Immunological synergistic antitumor therapy
    Muse Ji, Hongbing Liu, Xinxin Liang, Mingli Wei, Dongmei Shi, Jingxin Gou, Tian Yin, Haibing He, Xing Tang, Yu Xin Zhang · 2024 · Chemical Engineering Journal
  53. STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs)
    Jiale Liu, Chenmian Liu, Yana Ma, Xiyu Pan, Ran Chu, Shu Yao, Junyu Chen, Chang Liu, Zhongshao Chen, Chenchen Sheng et al. · 2024 · Cancer Letters
  54. Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
    Yunxing Shi, Zongfeng Wu, Shaoru Liu, Dinglan Zuo, Yi Niu, Yuxiong Qiu, Liang Qiao, Wei A. He, Jiliang Qiu, Yunfei Yuan et al. · 2024 · Nature Communications
  55. Lung cancer research and treatment: global perspectives and strategic calls to action
    May‐Lucie Meyer, Solange Peters, Tony S.K. Mok, Stephen C. Lam, Pan‐Chyr Yang, C. Aggarwal, Julie Renee Brahmer, Rafał Dziadziuszko, Enriqueta Felip, Andrea A. Ferris et al. · 2024 · Annals of Oncology
  56. Personalized medicine: An alternative for cancer treatment
    Devendra Singh, Vinay Kumar Dhiman, Minakshi Pandey, Vivek Kumar Dhiman, Avinash Sharma, Himanshu Pandey, Sunil Kumar Verma, Rajeev Pandey · 2024 · Cancer Treatment and Research Communications
  57. KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma
    Carter Norton, Matthew Steven Shaw, Zach Rubnitz, Jarrod L. Smith, Heloisa Prado Soares, Chris Nevala-Plagemann, Ignacio Garrido‐Laguna, Vaia Florou · 2025 · JAMA Network Open
  58. Factors Associated with Body Image and Self-Esteem in Mastectomized Breast Cancer Survivors
    Sergio Álvarez-Pardo, José António de Paz Fernández, Ena Monserrat Romero-Pérez, Kora Portilla-Cueto, Mario Alberto Horta-Gim, Jeronimo Javier Gonzalez-Bernal, Jessica Fernández-Solana, Juan Mielgo‐Ayuso, Adrián García-Valverde, Josefa González‐Santos · 2023 · International Journal of Environmental Research and Public Health
  59. Nutritional Management of Patients with Head and Neck Cancer—A Comprehensive Review
    Dinko Martinović, Daria Tokić, Ema Puizina Mladinić, Mislav Usljebrka, Sanja Kadić, Antonella Lešin, Marino Vilović, Slaven Lupi-Ferandin, Sasa Ercegovic, Marko Kumrić et al. · 2023 · Nutrients
  60. Formulating co-loaded nanoliposomes with gallic acid and quercetin for enhanced cancer therapy
    Ali Mahmoud Al-Samydai, Moath Alqaraleh, Khaldun M. Al Azzam, Amal H. Mayyas, Hamdi Nsairat, Maha N. Abu Hajleh, Lidia Kamal Al‐Halaseh, Nehaya Al‐Karablieh, Amal A. Akour, Fatima Alshaik et al. · 2023 · Heliyon
  61. Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS)
    Sandip M. Prasad, William C. W. Huang, Neal D. Shore, Brian Robin Hu, Marc A. Bjurlin, Gordon Andrew Brown, Pencho P. Genov, Dimitar Shishkov, Alexandre Khuskivadze, Tosho Ganev et al. · 2023 · The Journal of Urology
  62. An Overview of Endometrial Cancer with Novel Therapeutic Strategies
    Theresa M. Kuhn, Saeeda Dhanani, Sarfraz Ahmad · 2023 · Current Oncology
  63. Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques
    Aldona Kasprzak · 2023 · Cancers
  64. Applications of Degradable Hydrogels in Novel Approaches to Disease Treatment and New Modes of Drug Delivery
    Bo Hu, Jinyuan Gao, Yu Lu, Yuji Wang · 2023 · Pharmaceutics
  65. AZGP1P2/UBA1/RBM15 Cascade Mediates the Fate Determinations of Prostate Cancer Stem Cells and Promotes Therapeutic Effect of Docetaxel in Castration-Resistant Prostate Cancer via TPM1 m6A Modification
    Hong Wang, Ji Liu, Xiaojun Zhu, Bin Yang, Zuping He, Xudong Yao · 2023 · Research
  66. Acral melanoma: new insights into the immune and genomic landscape
    Larissa Anastácio da Costa Carvalho, Flávia Carvalho Aguiar, Keiran S.M. Smalley, Patrícia A. Possik · 2023 · Neoplasia
  67. Recent advances and remaining challenges in lung cancer therapy
    Tasha Barr, Shoubao Ma, Zhixin Li, Jianhua Yu · 2024 · Chinese Medical Journal
  68. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
    Lea Monteran, Nour Ershaid, Ye’ela Scharff, Yazeed Zoabi, Tamer Sanalla, Yunfeng Ding, Anna Pavlovsky, Yael Zait, Marva Langer, Tal Caller et al. · 2024 · Cancer Discovery
  69. Environmental Pollution and Risk of Childhood Cancer: A Scoping Review of Evidence from the Last Decade
    María del Pilar Navarrete-Meneses, Consuelo Salas‐Labadía, Fernando Gómez‐Chávez, Patricia Pérez‐Vera · 2024 · International Journal of Molecular Sciences
  70. The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial
    Elena Giudice, Tzu‐Ting Huang, Jayakumar R. Nair, Grant Zurcher, Ann McCoy, Darryl Nousome, Marc R. Radke, Elizabeth M. Swisher, Stanley Lipkowitz, Kristen R. Ibanez et al. · 2024 · Nature Communications
  71. IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer
    Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng et al. · 2024 · Cancer Research
  72. Bacterial derivatives mediated drug delivery in cancer therapy: a new generation strategy
    Muhammad Ijaz, Ikram Hasan, Tamoor Hamid Chaudhry, Rui Huang, Lan Zhang, Ziwei Hu, Qingqin Tan, Bing Guo · 2024 · Journal of Nanobiotechnology
  73. Metal‐coordinated amino acid/peptide/protein‐based supramolecular self‐assembled nanomaterials for anticancer applications
    Maryam Shabbir, Atia Atiq, Jiahua Wang, Maria Atiq, Nyla Saeed, İbrahim Yıldız, Xuehai Yan, Ruirui Xing, Manzar Abbas · 2024 · Aggregate
  74. The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression
    Zhuoran Gu, Libin Zou, Xinjian Pan, Yang Yu, Yongqiang Liu, Zhijin Zhang, Ji Liu, Shiyu Mao, Junfeng Zhang, Chuanyong Guo et al. · 2024 · MedComm
  75. Artificial intelligence-enhanced risk stratification of cancer therapeutics-related cardiac dysfunction using electrocardiographic images
    Oikonomou, Evangelos K., Sangha, Veer, Dhingra, Lovedeep S., Aminorroaya, Arya, Coppi, Andreas, Krumholz, Harlan M., Baldassarre, Lauren A., Khera, Rohan · 2025 · Circulation: Cardiovascular Quality and Outcomes
  76. Mucins as Potential Biomarkers for Early Detection of Cancer
    Shailendra Kumar Gautam, Parvez Κhan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar Kishor Ganti, Surinder K. Batra, Mohd Wasim Nasser, Maneesh Jain · 2023 · Cancers
  77. Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies
    Alyssa L. Becker, Arup K. Indra · 2023 · Cancers
  78. Inhibitory Potential of Resveratrol in Cancer Metastasis: From Biology to Therapy
    Baohong Song, Wei Wang, Xuemei Tang, Robby Miguel Goh, Win Lwin Thuya, Paul C. Ho, Lu Chen, Lingzhi Wang · 2023 · Cancers
  79. Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications
    Britta Weigelt, Antonio Marra, Pier Selenica, Eric Rios‐Doria, Amir Momeni Boroujeni, Michael F. Berger, Kanika S. Arora, David Nemirovsky, Alexia E. Iasonos, Debyani Chakravarty et al. · 2023 · Cancer Discovery
  80. Point‐of‐Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip
    Giulia Moro, Chiara Dalle Fratte, Nicola Normanno, Federico Polo, Stefano Cinti · 2023 · Angewandte Chemie International Edition
  81. KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer
    Yong Wu, Siyu Chen, Yang Washington Shao, Ying Su, Qin Li, Jiangchun Wu, Jun Zhu, Hao Wen, Yan Huang, Zhong Zheng et al. · 2023 · Advanced Science
  82. Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma
    Nanami L. Miyazaki, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi · 2023 · Cancers
  83. Triple coumarin-based 5-fluorouracil prodrugs, their synthesis, characterization, and release kinetics
    Yasser Fakri Mustafa · 2023 · Journal of Molecular Structure
  84. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer
    Wenhao Wang, Tiewen Li, Zhiwen Xie, Jing Zhao, Yu Zhang, Yuan Ruan, Bangmin Han · 2024 · Journal of Translational Medicine
  85. Nanoparticle-integrated dissolving microneedles for the co-delivery of R848/aPD-1 to synergistically reverse the immunosuppressive microenvironment of triple-negative breast cancer
    Sicong Huang, Ting Wen, Jiachen Wang, Huiye Wei, Zecong Xiao, Bo Li, Xintao Shuai · 2024 · Acta Biomaterialia
  86. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
    Na Song, Kai Cui, Liqun Zeng, Mengxiao Li, Yanwu Fan, Pingyu Shi, Ziwei Wang, Wei Su, Haijun Wang · 2024 · European Journal of Pharmacology
  87. Nucleic acid-based drugs for patients with solid tumours
    Sebastian G. Huayamares, David Loughrey, Hyejin Kim, James E. Dahlman, Eric J. Sorscher · 2024 · Nature Reviews Clinical Oncology
  88. Metabolic adaptations in cancer stem cells: A key to therapy resistance
    Matthew Masoudi, Dilpreet Moti, Raha Masoudi, Abdul Auwal, M. Matakabbir Hossain, Tasfik Ul Haque Pronoy, K M Rashel, Vinod Gopalan, Farhadul Islam · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  89. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States
    Isla P. Garraway, Sigrid Carlsson, Yaw A. Nyame, Jason L. Vassy, Marina Chilov, Mark T. Fleming, Stanley K. Frencher, Daniel J. George, Adam Stuart Kibel, Sherita A. King et al. · 2024 · NEJM Evidence
  90. Organic dye-based photosensitizers for fluorescence imaging-guided cancer phototheranostics
    Rui Wang, Siwei Hua, Yanlong Xing, Rui Wang, Huimin Wang, Tongmeng Jiang, Fabiao Yu · 2024 · Coordination Chemistry Reviews
  91. CAR memory–like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer
    Mubin Tarannum, Khanhlinh Dinh, Juliana A. Vergara, Grace Caroline Birch, Yasmin Z. Abdulhamid, Isabel E. Kaplan, Oyku Ay, Andreia Maia, Owen Beaver, Michal Sheffer et al. · 2024 · Science Advances
  92. Rhein: An Updated Review Concerning Its Biological Activity, Pharmacokinetics, Structure Optimization, and Future Pharmaceutical Applications
    Yuqi Fu, Le Yang, Lei Liu, Ling Dong Kong, Hui Juan Sun, Ye Sun, Fengting Yin, Guangli Yan, Xijun Wang · 2024 · Pharmaceuticals
  93. mRNA vaccines in the context of cancer treatment: from concept to application
    Qiang Fu, Xiaoming Zhao, Jinxia Hu, Yang Jiao, Yunfei Yan, Xuchen Pan, Xin Wang, Fei Jiao · 2025 · Journal of Translational Medicine
  94. Marine natural products as a source of novel anticancer drugs: an updated review (2019–2023)
    Hesham Rushdey El-Seedi, Mohamed S. Refaey, Nizar Elias, Mohamed F. El-Mallah, Faisal F. Albaqami, Ismail Dergaa, Ming Du, Mohamed F. Salem, Haroon Elrasheid Tahir, Maria Daglia et al. · 2025 · Natural Products and Bioprospecting
  95. Cancer of the ovary, fallopian tube, and peritoneum: 2025 update
    Malte Renz, Michael Leonard Friedlander, Jonathan S. Berek · 2025 · International Journal of Gynecology & Obstetrics
  96. A multi-class deep learning model for early lung cancer and chronic kidney disease detection using computed tomography images
    Ananya Bhattacharjee, Sameh Rabea, Abhishek Bhattacharjee, Eslam B. Elkaeed, R. Murugan, Heba Mohammed Refat M. Selim, Ram Kumar Sahu, Gamal A. Shazly, Mounir Mohamed Salem-Bekhit · 2023 · Frontiers in Oncology
  97. Bioactivities and Mechanisms of Action of Sinomenine and Its Derivatives: A Comprehensive Review
    Wen Hou, Lejun Huang, Hao Huang, Shenglan Liu, Wei Dai, Jianhong Tang, Xiangzhao Chen, Xiaolu Lu, Qisheng Zheng, Zhinuo Zhou et al. · 2024 · Molecules
  98. Exosomal lncRNA XIST promotes perineural invasion of pancreatic cancer cells via miR-211-5p/GDNF
    Ke Cheng, Jinjin Pan, Qinlong Liu, Yuke Ji, Liang Liu, Xiangqian Guo, Qiang Wang, Shao Li, Sun Jinyue, Miaomiao Gong et al. · 2024 · Oncogene
  99. TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers
    Tushar D. Nichakawade, Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang, Sarah R. DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie A. Glavaris et al. · 2024 · Nature
  100. The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma
    Faria Nusrat, Akshay Khanna, Aditi Jain, Wei Jiang, Harish Lavu, Charles J. Yeo, Wilbur Bo Bowne, Avinoam Nevler · 2024 · Journal of Clinical Medicine